Ticker >

Kerala Ayurveda share price

Kerala Ayurveda Ltd.

BSE: 530163 SECTOR: Pharmaceuticals & Drugs  25k   35   1

300.00
+5.95 (2.02%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 300.9

Today's Low

₹ 287.1

52 Week High

₹ 346.6

52 Week Low

₹ 100.5

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

360.97 Cr.

Enterprise Value

422.88 Cr.

No. of Shares

1.2 Cr.

P/E

145.03

P/B

8.93

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  33.58

CASH

0.55 Cr.

DEBT

62.45 Cr.

Promoter Holding

58.58 %

EPS (TTM)

₹  2.07

Sales Growth

13.44%

ROE

29.02 %

ROCE

10%

Profit Growth

224.98 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.44%
3 Year5.64%
5 Year7.66%

Profit Growth

1 Year266.19%
3 Year54.87%
5 Year7.2%

ROE%

1 Year29.02%
3 Year-4.12%
5 Year0.46%

ROCE %

1 Year10%
3 Year6.52%
5 Year5.67%

Debt/Equity

5.3535

Price to Cash Flow

39.58

Interest Cover Ratio

1.4929987119292

CFO/PAT (5 Yr. Avg.)

34.2504593668305

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 58.58 0
Dec 2023 63.44 7.45
Sep 2023 61.52 8.09
Jun 2023 61.52 46.55
Mar 2023 61.52 100
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.644644870759917.
  • The company has an efficient Cash Conversion Cycle of -25.8632782663698 days.
  • The company has a good cash flow management; CFO/PAT stands at 34.2504593668305.
  • The company has a high promoter holding of 58.58%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 22.1050848363396.

 Limitations

  • The company has shown a poor revenue growth of 5.64470362323433% for the Past 3 years.
  • Company has a poor ROE of -4.11877007005503% over the past 3 years.
  • Company has high Debt to Equity ratio of 5.3535.
  • The company is trading at a high EV/EBITDA of 80.3026.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 15.27 15.09 15.86 18.75 17.28
Total Expenditure 14.8 13 14.06 18.18 16.81
Operating Profit 0.47 2.09 1.8 0.57 0.46
Other Income 0.05 0.02 0.06 0.21 0.08
Interest 1.07 1.22 1.4 0.45 0.48
Depreciation 0.18 0.12 0.19 0.18 0.2
Exceptional Items 2.84 0 0 0.53 0
Profit Before Tax 2.11 0.78 0.28 0.68 -0.13
Tax 0.53 -1.27 0.07 0.17 0.14
Profit After Tax 1.58 2.04 0.21 0.51 -0.27
Adjusted EPS (Rs) 1.5 1.93 0.2 0.48 -0.24

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 46.49 53.68 43.2 55.8 63.3
Total Expenditure 43.49 50.58 43 48.07 58.54
Operating Profit 3 3.11 0.21 7.73 4.76
Other Income 0.26 0.16 0.17 0.3 0.23
Interest 2.23 1.37 6.14 6.03 4.81
Depreciation 0.56 0.68 0.82 0.77 0.64
Exceptional Items 1.28 0 0 0 2.83
Profit Before Tax 1.75 1.22 -6.58 1.23 2.37
Tax 0.55 0.34 -1.63 0.35 -0.52
Net Profit 1.2 0.88 -4.95 0.89 3.26
Adjusted EPS (Rs.) 1.14 0.83 -4.69 0.84 2.74

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 10.56 10.56 10.56 10.56 10.56
Total Reserves 2.94 4.11 -0.51 0.72 3.98
Borrowings 45.08 47.16 47.85 28.76 40.43
Other N/C liabilities 8.83 9.49 7.83 4.16 3.75
Current liabilities 19.76 22.28 29.79 47.13 37.92
Total Liabilities 87.16 93.6 95.51 91.33 96.63
Assets
Net Block 16.62 17.09 16.8 27.96 30.32
Capital WIP 9.94 11.55 11.98 2.34 0
Intangible WIP 0 0 0 0 0
Investments 11.47 11.47 11.37 11.37 11.37
Loans & Advances 21.32 23.03 24.5 22.07 27.12
Other N/C Assets 0.37 3.08 3.07 4.19 3.04
Current Assets 27.44 27.38 27.8 23.39 24.79
Total Assets 87.16 93.6 95.51 91.33 96.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 3.83 2.44 -0.53 7.12 6.81
Adjustment -6.35 0.82 0.97 0.81 0.95
Changes in Assets & Liabilities 12.5 1.45 -1.35 0.82 1.35
Tax Paid -0.64 0 0 0 0
Operating Cash Flow 9.34 4.71 -0.91 8.75 9.12
Investing Cash Flow -1.7 -3.93 -2.1 0.83 -5.32
Financing Cash Flow -11.14 0.29 2.18 -10.52 -3.38
Net Cash Flow -3.5 1.06 -0.83 -0.94 0.41

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 61.52 61.52 61.52 63.44 58.58
katra holdings ltd 61.52 61.52 61.52 58.44 53.97
katra phytochem india pri... - - - - 4.61
katra phytochem (india) p... - - - 5.00 -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 38.48 38.48 38.48 36.56 41.42
anilkumar k - - - - 1.60
dheeraj kumar lohia 2.05 2.26 2.27 2.20 2.03
llp - - - 0.07 0.60
porinju veliyath 1.89 3.18 3.18 4.82 5.18
sanjiv dhireshbhai shah - - - - 2.89
sashikanth balachandar - 1.03 1.03 - 1.26
anil kumar k 1.90 1.90 1.90 1.76 -
margin trading account-in... - - - 0.02 -
margin trading account-co... 0.01 0.03 0.02 - -
shon randhawa 4.71 4.71 4.49 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Kerala Ayurveda - Quaterly Results14 Feb 2024, 3:29PM Kerala Ayurveda - Quaterly Results14 Feb 2024, 3:29PM Kerala Ayurveda informs about certificate6 Jan 2024, 9:52AM Kerala Ayurveda - Quaterly Results14 Nov 2023, 12:00PM Kerala Ayurveda - Quaterly Results14 Nov 2023, 12:00PM Kerala Ayurveda informs about disclosure 12 Oct 2023, 12:34PM Kerala Ayurveda informs about certificate6 Oct 2023, 10:45AM Kerala Ayurveda informs about book closure8 Sep 2023, 3:30PM Kerala Ayurveda informs about AGM notice 6 Sep 2023, 9:54AM Kerala Ayurveda - Quaterly Results10 Aug 2023, 4:14PM Kerala Ayurveda - Quaterly Results10 Aug 2023, 4:14PM Kerala Ayurveda gets nod to enter into BTA for purchase of Nutraceutical product range 12 Jul 2023, 4:17PM Kerala Ayurveda informs about compliance certificate4 Jul 2023, 11:55AM Kerala Ayurveda informs about press release15 Feb 2023, 2:33PM Kerala Ayurveda - Quaterly Results14 Feb 2023, 1:54PM Kerala Ayurveda receives patent from USPTO 14 Dec 2022, 4:22PM Kerala Ayurveda informs about closure of trading window1 Oct 2022, 4:03PM Kerala Ayurveda informs about trading window closure29 Jun 2022, 5:11PM Kerala Ayurveda informs about on-applicability of large corporate entity13 Apr 2022, 12:55PM Kerala Ayurveda informs about closure of trading window30 Dec 2021, 12:13PM Kerala Ayurveda informs about disclosure18 Dec 2021, 10:51AM Kerala Ayurveda informs about updates20 Nov 2021, 12:18PM Kerala Ayurveda Informs about proceedings of AGM1 Oct 2021, 12:42PM Kerala Ayurveda informs about board meeting7 Aug 2021, 4:46PM Kerala Ayurveda informs about RTA certificate5 Jul 2021, 2:46PM Kerala Ayurveda informs about declaration3 Jul 2021, 2:09PM Kerala Ayurveda informs about compliance report30 Jun 2021, 5:02PM Kerala Ayurveda informs about closure of trading window 29 Jun 2021, 10:46AM Kerala Ayurveda partners with eBay4 Mar 2021, 12:37PM Kerala Ayurveda informs about press release4 Mar 2021, 10:40AM Kerala Ayurveda informs about notice of board meeting4 Nov 2020, 1:34PM Kerala Ayurveda launches Tele-Consultation ‘DigiApp’ 4 Nov 2020, 10:17AM Kerala Ayurveda informs about compliance certificate7 Oct 2020, 10:35AM Kerala Ayurveda informs about related party transactions18 Jul 2020, 3:21PM Kerala Ayurveda informs about company updates 13 Apr 2020, 3:33PM

Kerala Ayurveda Stock Price Analysis and Quick Research Report. Is Kerala Ayurveda an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kerala Ayurveda and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Kerala Ayurveda cash from the operating activity was Rs 9.119 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kerala Ayurveda has a Debt to Equity ratio of 5.3535 , which is a weak indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kerala Ayurveda , the EPS growth was 224.969789990137 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kerala Ayurveda has OPM of 7.52021763480133 % which is a bad sign for profitability.
     
  • ROE: Kerala Ayurveda have a healthy ROE of 29.0188677351189 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Kerala Ayurveda is Rs 293.5. One can use valuation calculators of ticker to know if Kerala Ayurveda share price is undervalued or overvalued.
Last Updated on:
Brief about Kerala Ayurveda
X